The approval, according to a notice from the FDA, was based on efficacy data from ... treatment paradigm in patients with ...
The FDA has granted fast track designation to HC-7366 for the treatment of adult patients with relapsed/refractory acute ...
Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic ... detects the presence of these gene fusions in acute promyelocytic leukemia (APL) and chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback